Four Peer-Reviewed Clinical Study Publications Build a Substantial Evidence Base for Oxaloacetate CFS in ME/CFS and Long COVID
Research published in the Journal of Translational Medicine, Frontiers in Neurology and Frontiers in Neuroscience journals finds oxaloacetate improves ME/CFS and Long COVID symptoms including physical fatigue, mental fatigue, cognition, symptom burden and upright activity. - August 18, 2026
Press Releases 1 - 1 of 1